Carbon-based smart nanomaterials in biomedicine and neuroengineering by Monaco, A. M. & Giugliano, M.
1849
Carbon-based smart nanomaterials in biomedicine
and neuroengineering
Antonina M. Monaco1 and Michele Giugliano*1,2,3
Review Open Access
Address:
1Theoretical Neurobiology and Neuroengineering Lab, Department of
Biomedical Sciences, University of Antwerp, Universiteitsplein 1,
B-2610 Wilrijk, Belgium, 2Brain Mind Institute, Swiss Federal Institute
of Technology, Lausanne, CH-1015, Switzerland and 3Department of
Computer Science, University of Sheffield, S1 4DP Sheffield, UK
Email:
Michele Giugliano* - michele.giugliano@uantwerpen.be
* Corresponding author
Keywords:
carbon nanotubes; electrophysiology; graphene; microelectrodes;
nanodiamonds; nanotechnology; neuroengineering; neuronal cultures;
neuroscience
Beilstein J. Nanotechnol. 2014, 5, 1849–1863.
doi:10.3762/bjnano.5.196
Received: 25 June 2014
Accepted: 29 September 2014
Published: 23 October 2014
This article is part of the Thematic Series "Atomic scale interface design
and characterisation: Theory – Structure and dynamics".
Guest Editor: C. Ewels
© 2014 Monaco and Giugliano; licensee Beilstein-Institut.
License and terms: see end of document.
Abstract
The search for advanced biomimetic materials that are capable of offering a scaffold for biological tissues during regeneration or of
electrically connecting artificial devices with cellular structures to restore damaged brain functions is at the forefront of interdiscip-
linary research in materials science. Bioactive nanoparticles for drug delivery, substrates for nerve regeneration and active guid-
ance, as well as supramolecular architectures mimicking the extracellular environment to reduce inflammatory responses in brain
implants, are within reach thanks to the advancements in nanotechnology. In particular, carbon-based nanostructured materials,
such as graphene, carbon nanotubes (CNTs) and nanodiamonds (NDs), have demonstrated to be highly promising materials for
designing and fabricating nanoelectrodes and substrates for cell growth, by virtue of their peerless optical, electrical, thermal, and
mechanical properties. In this review we discuss the state-of-the-art in the applications of nanomaterials in biological and biomed-
ical fields, with a particular emphasis on neuroengineering.
Introduction
Over the past few years, the gap between materials sciences and
biology has increasingly narrowed. This has enabled substan-
tial progress within interdisciplinary approaches, particularly in
those combining micro- and nanotechnologies in biological and
biomedical applications. For example, the field of neuroengin-
eering was established, as a recent new research discipline
within the field of neuroscience. Neuroengineering focuses on
the development of artificial devices and novel materials to be
functionally and structurally interfaced with the central nervous
system (CNS). Among its ultimate goals, repairing, replacing,
and enhancing the function of damaged brain tissue is a priority,
as witnessed by the recent progress in (pre)clinical neuropros-
thetics and brain pacemakers. At the same time, neuroengin-
eering also deals with serious clinical challenges, due to the
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unique anatomy and physiology of the CNS, compared to other
organs. Today, there is the expectation that materials science
and nanotechnology will be able to address these challenges and
lead to breakthroughs at the level of the interfaces between arti-
ficial transducers/actuators and living cells.
Nowadays, fundamental research in neuroengineering aims to
open up new frontiers in tissue engineering through recon-
structive/repairing strategies that will ultimately be able to
provide a functional bridge to the damaged tissue and restore
functions via implantable assisting devices. This calls for the
use of new smart materials, whose interactions with living
tissue can be controlled, engineered and modified. Nanomater-
ials are ideal candidates for such applications and by virtue of
their nanoscale dimensions, share with biological (sub)cellular
structures a similar level of organisation. This review presents
some of the recent applications of nanomaterials that were
reported in very recent years with an emphasis on carbon-based
materials.
Review
Carbon and its nanoderivatives: chemical
and physical properties
In nature, carbon is found in different forms or allotropes,
depending on its chemical valence. The electron configuration
of carbon in its fundamental state (1s2 2s2 2p2) is such that it
can form, at the most, two covalent bonds. However, in its
chemical compounds, carbon is able to form up to four cova-
lent bonds thanks to a rearrangement of its electron configur-
ation: One of its 2s electrons “moves” into the empty 2p orbital,
giving rise to four bonds due to four hybrid orbitals. The three
possible hybridisations (sp, sp2 and sp3) differ according to the
number of p orbitals mixed with the s orbital, and according to
the angle between the orbitals themselves. This angle, in turn,
defines the type of chemical bond carbon can establish; these
consist of only simple bonds (σ type) in sp3 hybridisation,
double bonds (one σ and one π) in sp2, and triple bonds (one σ
and two π) in sp.
Among the existing allotropes, the most widely known are
carbon nanotubes (CNTs) and fullerenes, graphite and graphene
(sp2), and diamond (sp3). From these distinct hybridisations,
different properties are inherent to these allotropes.
Carbon nanotubes (CNTs): CNTs, first reported by Iijima in
1991 [1], are hollow cylinders made of one (i.e., single-walled
CNTs, SWCNTs) or several (i.e., multi-walled CNTs,
MWCNTs) layers of graphene. They are obtained by a variety
of methods, including chemical vapour deposition (CVD) and
arc-discharge, and their electronic properties depend solely on
geometric parameters, such as diameter and chiral angle. These
parameters are in turn determined by the magnitude and the
direction of the chiral vector [2], and their influence is clearly
expressed in the electrical conductivity of the CNTs: SWCNTs
can be either metallic or semiconducting [3], while MWCNTs
show only metallic behaviour [4]. Moreover, the mechanical
and electronic properties of SWCNTs can be altered by means
of external electric fields [5,6].
The chemical bonds between carbon atoms in CNTs are among
the strongest known and this, combined with their character-
istic tubular structure, endows CNTs with an extremely high
mechanical strength [7], while at the same time exhibiting a
very low weight. Combined with a large surface area, these
electronic and mechanical properties give CNTs a great poten-
tial for microelectronics and optics, and also for biomedical
applications (e.g., as nanoelectrodes for neural stimulation and
functional scaffolds for tissue engineering).
Nanodiamonds (NDs): As a result of the complete sp3 hybrid-
isation of its carbon atoms and its characteristic tetrahedral con-
figuration, diamond shows interesting and peculiar properties
such as an extreme hardness, low friction coefficient, high
mobility of electrical charge carriers and high thermal conduct-
ivity [8,9]. Diamond exhibits these properties both in bulk as
well as at the nanoscale and combines them with typical
features of nanomaterials, such as a large surface area and small
overall size.
NDs, mainly obtained by detonation of TNT-like explosives
under oxygen-deprived conditions, are core–shell like particles
with a diameter of 2–8 nm. Their structure consists of an sp3-
hybridised core surrounded by layers of amorphous and sp2-
hybridised carbon [10-12], and they show a strong tendency
to agglomerate [13] in clusters with sizes ranging from
100–200 nm to 20–30 μm. This tendency is likely the
consequence of several surface terminations, all containing
oxygen functional groups such as carboxyl, hydroxyl, ketone
and lactone. Ad hoc surface functionalisation of NDs is thus
essential for improving the solubility of NDs and to make them
suitable for biological applications [14].
The optical properties of NDs are remarkable: highly pure
diamond is fully transparent and colourless, whereas the pres-
ence of lattice impurities and dopants render diamond coloured
[15]. When NDs are excited by UV light [16], they display
fluorescence over a broad emission band in the visible region
[17] of the spectrum. One of the most common and studied
defects in diamond lattice is the nitrogen-vacancy centre (NV
centre) [18], formed by a lattice vacancy and an adjacent
nitrogen atom in the NDs. The importance of these NV centres
lies in their magnetic properties [19]: Given the coupling
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between the spin state and luminescence, the luminescence of
NDs can be modulated by local magnetic fields [20,21].
Graphene: Graphene is a mono-atomic, two-dimensional, sheet
of sp2-hybridised carbon atoms arranged as a honeycomb
lattice. Since the first single-layer sample was isolated from
graphite by Novoselov and colleagues [22] in 2004, graphene
has attracted substantial interest and attention for its unique
chemical and physical properties, because its existence had for a
long time been considered to be impossible [23,24].
Its special electronic structure bestows graphene uncommon
and astonishing electronic properties, such as the quantum Hall
effect, which can be observed even at room temperature [25], a
very high electron mobility [26], the ambipolar electric field
effect, the ballistic conduction of electronic charge carriers [27],
as well as the nature of the charge carriers themselves, which
behave like massless relativistic particles and are thus better
described by Dirac’s rather than Schrödinger’s equation [28].
These, and other remarkable properties, including its excellent
mechanical strength [29], the high transparency of single-layer
graphene [30], and its large surface area [31], make graphene
and graphene oxide (GO) one of the most promising materials
for technological and biomedical applications.
Carbon-based nanomaterials in biomedical
applications
The peculiar ability of several nanomaterials to functionally
integrate with biological systems is a consequence of their inter-
actions with cells and membranes occurring at the subcellular
level. However, due to their chemically inert surface and van
der Waals forces occurring at the surface, carbon-based nano-
materials, particularly pristine CNTs, tend to agglomerate,
which results in a limited dispersion in organic matrices. To
overcome this problem and to improve the biocompatibility, or
to specify the targeting of the particles, functionalisation
methods have been developed and successfully used in the past
decade. In the following paragraphs, we review some of the
most important biological applications of these nanomaterials.
CNTs: The previously mentioned large surface area and their
excellent chemical stability confers CNTs the ability to
conjugate and absorb several therapeutic molecules, paving the
way for using them as drug- and gene-delivery systems. Yang
and colleagues [32], for example, exploited the ability of CNTs
to cross the blood–brain barrier to deliver acetylcholine into
the lysosomes of neurons in the experimental treatment of
Alzheimer’s disease in mice.
However, the biological applications of CNTs require their
complete purification from both metal and carbonaceous
particles [33]. In addition, their surface functionalisation must
be designed to enhance their solubility in biological media [34].
In particular, two functionalisation procedures for CNTs are
explored in the literature: (i) the non-covalent approach [35,36]
that consists of coating CNTs with surfactants, peptides, poly-
mers, or nucleic acids, which preserve their aromatic structure,
and (ii) the covalent approach [37-39], by means of applying
several protocols, such as oxidation in strong acids, fluorin-
ation [40], and Bingel [41] and Billups [42] reactions.
Given the nature of their applications, biocompatibility of CNTs
is a crucial, yet still controversial point. How physicochemical
characteristics (i.e., length, diameter, and surface functionalisa-
tion) affect the toxicity of CNTs [43], and by what mechanisms
CNTs can enter the cellular cytoplasm, and where they are
localised once internalised [44], remain open questions. In fact,
both toxicity and biocompatibility have been reported and
discussed extensively for CNTs in recent literature. Inhalation
of pristine raw SWCNTs has been described to result in changes
in pulmonary functions, inflammatory reactions, and the forma-
tion of granulomas [45]. Granulomas and inflammatory reac-
tions have also been reported upon injection of CNTs in the
peritoneal cavity, likely as a consequence of their asbestos-like
structure [46]. The toxic effects of raw CNTs have also been
reported in vitro [47-50], interpreted as a likely consequence of
their hydrophobic surface and as a result, their tendency to
aggregate. However, these adverse effects appear to be reduced
for functionalised CNTs [49,50]. Therefore, the cyto- and geno-
toxicity of CNTs appear to be sample-specific, and require the
evaluation of biocompatibility properties on a case-by-case
basis.
Despite the debate on their biocompatibility when in solution,
CNTs have been proposed as an ideal material over quite a wide
range of biomedical applications; in addition to the discussed
drug [51] and gene [52,53] delivery, CNTs have been used as
biosensors [54], in hyperthermia therapy for tumours [55,56],
in tissue engineering [57], for in vivo [58] and in vitro [59]
imaging.
The electrical conductivity of CNTs lies at the foundation of the
proposal for employing CNTs as smart-scaffolds for excitable
cells such as neurons [60] and cardiac cells [61], within regen-
erative applications. Martinelli et al. [62,63] cultured neonatal
rat ventricular myocytes on CNTs substrates and measured the
active and passive membrane electrical properties of both single
myocytes and multinucleated cells by patch-clamp cellular elec-
trophysiology. In both cases, cells grown on CNTs substrates
showed a more negative resting potential compared to the
control condition, while no significant differences were found
for input resistance and cell capacitance or for the occurrence
Beilstein J. Nanotechnol. 2014, 5, 1849–1863.
1852
frequency and kinetics of action potentials (APs). However, this
study further highlighted that interfacing cardiomyocytes with
CNTs accelerates cells maturation, resulting in an increased
expression of mature phenotype-related genes.
Lin and colleagues [64] studied in vitro how pristine
SWCNTs dispersed in an extracellular medium can affect the
viability of vascular adventitial fibroblasts and their transfor-
mation into myofibroblasts. Their results showed an up-regu-
lated expression of a specific differentiation marker, accom-
panied, however, by an increased generation of the most bio-
logically significant free radicals, the reactive oxygen species
(ROS).
NDs: Among the applications of NDs, the most important
include drug delivery [65,66], implants coating [67] and
bioimaging [68]. Similarly to the use of CNTs, the first consid-
eration in biological applications is the biocompatibility of
NDs. Diamond, in its bulk form, is chemically inert. However,
because surface chemistry is predominant at the nanoscale
compared to that of the bulk scale, investigating ND biocompat-
ibility has been a priority in recent years.
One of the first studies in this area was conducted by Yu and
colleagues [69], who evaluated the cytotoxicity of fluorescent
NDs by employing human embryonic kidney cells: they
observed that NDs slightly affected cell viability, even for a
concentration of about 400 μg/mL.
Schrand and co-workers [70-72] extensively studied this issue
through standard in vitro cell viability assays (i.e., MTT) and
also monitored adenosine triphosphate (ATP) production
and ROS generation. They found that, compared to several
carbon-based alternative nanomaterials (i.e., carbon black,
SWCNTs and MWCNTs), NDs were the least toxic when
exposed to neuroblastoma cells, as they did not induce signifi-
cant ROS production and did not affect mitochondrial
membrane integrity.
A different approach to biocompatibility of NDs has been
proposed by several research groups, who monitored gene
expression of cells. No significant change in the expression of
Bcl-x and TNF-α genes [65] was found, while a decreased
expression of genes responding to genotoxic compounds was
described; in addition, no effects on the expression of genes
responding to oxidative stress were observed [73]. However,
Xing et al. [74] observed that embryonic stem cells responded
to incubation with NDs with an increased expression of
MOGG-1 and P53, which are proteins related to DNA repair
processes. This genotoxicity was increased when cells were in-
cubated with oxidised NDs, suggesting it was a specific
consequence of the surface chemistry of NDs. Nonetheless,
Xing and co-workers noted that NDs and oxidised NDs induce
overall less DNA damage than that caused by MWCNTs.
The investigation of the cellular uptake mechanisms of NDs
is also a key aspect for biological applications of NDs.
Vaijayanthimala and colleagues [75] reported that cellular
uptake was strictly related to the surface functionalisation of
NDs and that it took place through clathrin-mediated, energy-
dependent, endocytosis processes. Schrand et al. [76] also
investigated the uptake of fluorophore-conjugated NDs by
neuroblastoma cell line and observed that the fluorophore-
conjugation was not affected by the different pH conditions en-
countered during the uptake process. In addition, NDs were
described as localising mainly in endosomes, lysosome and in
some cases, the cytoplasm.
Given the possibility for NDs in powder form to spread in the
air during detonation synthesis, an in vivo evaluation of their
toxicity also became relevant and timely; several studies have
focused on this aspect and highlighted that NDs have no
remarkable adverse effects in the lungs [77]. In addition, subcu-
taneous exposure to NDs does not trigger inflammatory
responses and NDs do not affect the normal internal organs
development or reproductive abilities [78]. In vivo system-level
localisation of NDs, studied by labelling NDs with different
radionuclides, revealed that NDs preferentially localise in the
lungs, liver and spleen [79], and that the urinary system excrete
them [80].
Hydrogels and thin-films based on NDs have also been used as
drug delivery systems by virtue of their ease of surface func-
tionalisation and small size. They have been reported for
successfully delivering several anticancer drugs and preserving
their activity under biological conditions [81-84].
The affinity of NDs for protein adsorption has been finally util-
ised to separate recombinant proteins from Escherichia coli
[85], resulting not only in a radically faster process than the
commonly used purification treatments, but also in a high
degree of purity of the recovered proteins, which can be further
analysed by mass spectrometry [86].
Graphene: Graphene, graphene oxide (GO) and reduced
graphene oxide (r-GO) have been investigated as new biocom-
patible material by virtue of their unique properties, making
them suitable for a broad variety of applications. The biocom-
patibility of graphene is, however, still disputed, given that very
few studies are available and because several graphene forms
can be employed (i.e., single or few layer, nanosheets, GO,
r-GO) each with different chemical and physical properties.
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These differences can induce distinct toxicological responses in
biological systems and require a systematic investigation.
In vitro studies, carried out on human cell lines (i.e., HepG2,
BEAS-2B, PC12, hMSCs), have demonstrated that the cyto-
and genotoxicity of graphene depends on the dose, shape, and
size of the nanomaterial itself [87-89], as well as on the pres-
ence of metal contaminants and the residues of the GO prepar-
ation method in graphene samples [90].
Biomedical applications of graphene and its derivatives range
from photothermal tumour ablation therapy to biosensors, from
gene therapy [91] and drug delivery to substrates for
biomolecular imaging [92,93], and from tissue scaffolds [94] to
electrodes for neural stimulation [95].
For instance, Yang and colleagues [96] investigated the possi-
bility of using polyethylene glycol (PEG)-coated nanographene
sheets showing absorption in the near-infrared region as a
photothermal agent for in vivo cancer treatment, while scrutin-
ising the effects originating from different graphene sizes and
coatings [97].
Several research groups have focused on graphene as
biosensors. Dey et al. [98] developed an amperometric choles-
terol biosensor; Tang and co-workers [99] studied the electro-
chemical behaviour of reduced graphene sheet films as nicotin-
amide adenine dinucleotide (NADH) sensors, while Kim and
colleagues [100] and Sun and colleagues [101] studied
graphene/Pt-based sensors for the detection of dopamine, and
uric and ascorbic acids.
The presence of reactive functional groups and of localised
π-electrons, which promote the π–π bond with aromatic com-
pounds, render graphene a suitable candidate as a drug delivery
system. Several remarkable studies in this area have been
performed, including those involving the functionalisation of
GO by PEG and water-insoluble chemotherapeutic drugs [102],
as well as research involving sulfonic acid groups bound with
folic acid in order to target human breast cancer [103]. Further-
more, Weaver and co-workers [104], exploiting the conductive
properties of GO sheets, developed an electrically-controlled
system capable of a linear release profile of an anti-inflam-
matory drug.
Carbon-based nanomaterials in neuro-
science
The (sub)cellular organisation of the CNS and carbon-based
nanomaterials share some intriguing similarities. This has
inspired several research groups to explore the use of these
nanomaterials for developing nanosized sensing/actuating tech-
nologies, ultimately capable of functional interfacing with nerve
cells and brain tissue, in order to repair the brain on the
(sub)cellular scale.
CNTs: The first application of CNTs in neuroscience was the
exploration of CNTs thin-films as ex vivo neuronal growth
substrates [105]. Mattson and colleagues reported that
MWCNTs favoured neuronal adhesion although neurite
branching was reduced, with respect to control conditions. This
pioneering work laid the foundations for subsequent studies
aimed at establishing the ability of CNTs to support neural
adhesion. Since then, several studies [106] have revealed that
CNTs are able to guide neuronal adhesion and to impact neuro-
nal networks.
Microelectrode arrays (MEAs – extracellular recording and
stimulation of neuronal activity): MEAs are devices
consisting of metallic microelectrodes (i.e., made of Au, Pt, or
titanium nitrate) and embedded in a planar substrate, arranged
in an array and connected to an external electrical circuitry. By
using individual microelectrodes it is possible to stimulate or
record neural electrical activity non-invasively, both in vivo and
in vitro. For these applications, which represent the frontiers of
neuroprosthetics and brain pacemakers, MEAs should exhibit
excellent biocompatibility, large signal-to-noise ratio (S/N),
large charge-injection limits, and high spatial resolution. While
the latter aspect can be improved by microphotolitography and
ultimately designing smaller microelectrodes, reducing the elec-
trode surface exposed to the electrolyte or in close proximity to
neuronal cell membranes, has been shown to lead to a signifi-
cant electrochemical impedance of the interface, decreased
injected charge limits and poor S/N properties.
CNTs, by their excellent electrical properties and large surface
area, immediately presented themselves as top candidates for
the fabrication of a new class of electrodes [107-110]. Gabay
and colleagues [111] developed CNTs-MEAs with improved
electrochemical properties by synthesizing “islands” of CNTs
on silicon dioxide substrates, and confirmed the capability of
the device for recording the spontaneous activity of cultured rat
cortical neurons.
Gabriel and co-workers [112] deposited a solution of SWCNTs
onto conventional platinum electrodes of a MEA, thus
enhancing the electrical properties of the device and success-
fully tested it to record the extracellular activity of ganglion
cells in rabbit retinas as a potentially important step for retinal
prostheses.
Shein et al. [113] cultured neurons on specifically designed
microelectrode arrays in which CNTs had been deposited by
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CVD on TiN leads, and reported a direct electrical interfacing
between neurons and microelectrodes made of CNTs.
Deposition of CNTs onto TiN microelectrode arrays was
proposed by means of a micro-contact printing technique by
Fuchsberger and colleagues [114], and showed superior
recording properties compared to commercial TiN microelec-
trodes. The same microelectrodes were also employed to elec-
trically stimulate and record neuronal activity, as well as to
detect low concentrated amounts of dopamine.
To overcome the problems related to spatial resolution and S/N,
more recently Gerwig et al. [115] developed a PEDOT–CNT
composite that combined the ionic and electronic conductivity
of poly(3,4-ethylenedioxythiophene) (PEDOT), a conductive
polymer, with the high mechanical stability of CNTs. This
combination, employed as a coating layer of conventional
MEAs, resulted in reduced impedance, and thus in improved
performances not only when compared with TiN or Au elec-
trodes, but also compared to pure PEDOT electrodes. The inter-
pretation of this phenomenon can most likely be found in the
conductivity of the meshwork of CNTs, which enhances the
electrical conductivity of the whole composite. Furthermore,
PEDOT–CNTs-electrodes demonstrated excellent biocompatib-
ility, allowing for the adhesion of primary chicken cardiomyo-
cytes and the development of a two-dimensional syncytium,
accompanied by good quality recording after six and ten days in
vitro (DIV).
The MEAs thus far discussed are designed for in vitro electro-
physiological stimulation and recording; however, they are not
directly suitable for in vivo applications, in which flexible
substrates must be employed. Lin and colleagues [116] were the
first researchers to grow CNTs electrode arrays on a silicon sub-
strate, transfer it onto a flexible and biocompatible polymeric
film (Figure 1), and then successfully record the APs of cray-
fish nerve cords.
Another flexible MEA, completely made from CNTs that have
been embedded in a polymeric support, has been presented by
David-Pur et al. [117]. This device showed the same character-
istics as planar CNTs-MEAs, combined with the advantages of
being flexible and of consisting of a continuous rough surface,
i.e., the CNTs film, which was demonstrated to improve cell
adhesion.
Patch-clamp electrophysiology: One of the first studies
reporting on the electrical activity of in vitro neuronal networks
coupled to MWCNT-substrates was that of Lovat and
co-workers [118]. They were the first researchers to intracellu-
larly monitor the electrical activity of neurons developing ex
Figure 1: Flexible MEA developed by Lin and colleagues. SEM micro-
graphs showing vertically aligned CNTs on Parylene-C (a,b) and a
photo of the transparent flexible CNTs electrodes (c). Reproduced and
modified from [116] with permission. Copyright 2009 Elsevier.
vivo on CNT-substrates (Figure 2A–C). The researchers unex-
pectedly reported that CNTs had an effect on spontaneous
synaptic activity (Figure 2D–F).
Mazzatenta and colleagues [119] further characterised and
explored this phenomenon by culturing hippocampal neurons
on pristine SWCNT-substrates. They also stimulated neurons
electrically through the CNTs film and devised a mathematical
model for the description of the electrical interface between
neurons and CNTs. This work confirmed the improved synaptic
activity observed by Lovat et al. [118], though no remarkable
differences in cell morphology or neuronal density were found,
suggesting that the reason for the enhanced network activity
might have resulted from tighter connections between the neu-
ronal membranes and the conductive CNT-substrates.
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Figure 2: CNTs thin-films are optimal substrates for neuronal growth and development ex vivo (A–C) and improve spontaneous synaptic activity, as
shown by the increased frequency of (D) post-synaptic currents and of (E) action potentials. Reproduced and modified from [118] with permission.
Copyright 2005 American Chemical Society.
The presence of these intimate connections was then proved, by
means of transmission electron microscopy (TEM), high resolu-
tion scanning electron microscopy (HRSEM) and immunofluor-
escence confocal laser scanning (CLS) microscopy, also
conducted by Sorkin et al. [120], who suggested a correlation
between mechanical forces and neuronal outgrowth, and by
Cellot et al. [121], who reported a very tight yet discontinuous
contact between CNTs substrates and neuronal membranes.
Another remarkable aspect is that the passive properties of
the membrane (i.e., quantified in terms of electrical circuit
equivalent, as the input resistance, the membrane capacitance
and the resting membrane potential) were comparable to the
control conditions [118,119,121,122] (Figure 3d). Ultimately,
the increase in spontaneous activity, exhibited by neurons
in the presence of CNTs, was not a result of an altered cell
morphology.
Cellot and colleagues [121] also focused their efforts on the
occurrence of an electrical coupling between CNTs and cell
membranes. Using patch-clamp electrophysiology, they showed
that CNTs strongly impacted the electrical regenerative prop-
erties of neuronal membranes upon inducing depolarising after-
potentials, which might be related to Ca2+-mediated electrogen-
esis and backpropagating APs (Figure 3a,b). It is worth noting
that this behaviour was shown to be specifically attributable to
CNTs, as it was not observed in neurons growing on other
substrates exhibiting large electrical conductivity or nanoscale
roughness (Figure 3c). Moreover, in the same work, mathemat-
ical modelling and electrophysiology were used to probe a
contingent connection between the effects observed at single-
neuron level and those detected at the level of neuronal
networks, leading to the speculation that the tight discontinuous
connections observed between cell bodies and CNTs might act
as shortcuts and transfer electrical currents between different
neuronal compartments. Cellot and co-workers [123] also
investigated the effects of CNTs at the synaptic level and
observed not only that growing neurons on CNT-substrates
increased the possibility of finding synaptically-connected pairs
of cells, but also that CNTs affected synaptic plasticity.
Another interesting feature of CNT-based substrates is that they
are able to modulate the developmental onset of neuronal elec-
trical activity in culture, as reported by Fabbro and colleagues
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Figure 3: CNTs affect single-neuron excitability, inducing depolarising after-potentials (a). This behaviour is specifically attributable to CNTs, as it has
been observed neither for cells grown on smooth and electrically conducting indium tin oxide substrates (ito) nor on electrically-insulating RADA16
peptide thin-films (b), characterised by a similar nanoscale roughness s CNTs (c). The culture substrates do not alter the electrical passive properties
of neuronal membranes (d). Reproduced and modified from [121] with permission. Copyright 2009 Nature Publishing Group.
[122]. In their study, the researchers observed that spinal
neurons grown on CNTs scaffolds displayed an early develop-
mental onset for generating APs and voltage-gated currents, as
well as changes in the expression of genes involved in cell com-
munication, growth, differentiation and in neuronal maturation.
The chronic interface between CNTs and organotypic cultures
of embryonic mouse spinal cord and dorsal root ganglia has also
been investigated [124]. The researchers observed an improved
outgrowth of cellular processes emerging from the dorsal root
ganglia, despite having a slightly different morphology than in
control conditions. Patch-clamp experiments finally revealed
the effect of CNT on spontaneous electrical activity of spinal
networks (i.e., an increased amplitude of spontaneous postsyn-
aptic currents), as well as on neuronal signalling (i.e., increased
efficacy of synaptic responses, even for neurons located several
cell layers away).
NDs: ND particles and thin-films have found applications in
neurosciences as substrates for neuronal growth [125-127] and
as microelectrode material [128,129], by virtue of their peculiar
electrical and chemical properties and stability. Specht et al.
[125] were among the first to report on the suitability of ND as
a substrate material. By micro-contact printing, they deposited
laminin on NDs to form patterned microstructures, on which
they then observed the ordered growth of primary cortical
neurons.
Neuronal adhesion and cell excitability have been studied by
Ariano and co-workers [126] and by Thalhammer and
colleagues [130], who observed that oxygen functionalisation
[126] and deposition of a layer of 5–10 nm sized ND particles
(NDPs) [130] (Figure 4a) improved cell attachment and did not
compromise neuronal electrical activity. This has been quanti-
fied by patch-clamp electrophysiology in terms of activation of
voltage-gated Ca2+ channels [126] and of AP firing frequency
[130] (Figure 4b). In the same researches, synaptic connectivity
was also studied, by evoking inhibitory GABAergic responses
[126] and by monitoring the spontaneous excitatory postsyn-
aptic miniature currents (mEPSCs) [130]. The results showed
that culturing neurons on ND did not affect synaptic activity.
The use of ND as a platform material for neural interfaces [131]
has been studied both in vivo [132], ex vivo [133] and in vitro
[128]. For these applications, boron doping of ND [134,135]
has often been considered to bestow ND metallic properties,
thus enabling superior S/N performances in the detection of
neuronal activity and a wider electrochemical window for elec-
trical stimulation.
Ariano et al. [128] developed a ND-based device in order to
record the spontaneous extracellular electrical activity in a
murine neuronal cell line, which yielded results in good agree-
ment with recordings made by means of conventional MEAs
(Figure 5).
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Figure 4: Scanning electron micrographs show that, when exposed to
animal blood serum proteins, polycrystalline (PCD) and nanocrystal-
line diamond (NCD) substrates performed as good as glass or silicon
substrates (a). NDs coating did not alter single-cell excitability (b).
Reproduced and modified from [130] with permission. Copyright 2010
Elsevier.
Single-spin NV-NDs embedded in an artificial lipid bilayer
[136] and in a real cell membrane, in which there is a notable
potential drop between the extra- and intracellular compartment,
can be used as nanoscopic magnetic sensors of spin labels.
Considering the typical values of membrane thickness and
membrane potential, the order of magnitude for the expected
electric fields is 107 V·m−1, which can allow for the measure-
ment of membrane potentials over a millisecond time-scale in
real time.
Hall et al. [137] recently proposed the use of a single crystal
ND substrate containing a layer of NV as a non-invasive model
for a detection set-up based on Förster resonance energy
transfer and optically detected magnetic resonance.
Graphene: Researchers have only recently begun to investi-
gate graphene and its derivatives as potential scaffolds for neu-
ronal growth, and as a conductive polymer for bio-interfacing.
The interest that graphene has attracted was the result not only
of its excellent conductive properties, but also because its nano-
structure and its chemical stability render it a good candidate for
favouring cell adhesion.
Figure 5: Sketch of the device for recording the extracellular electrical
activity of cultured neuronal networks, developed by Ariano and
co-workers. Cells (4) are plated in the recording chamber (8), directly
onto hydrogen-terminated diamond (5). Reproduced from [128] with
permission. Copyright 2009 Elsevier.
In one of the first studies, Li and co-workers [138] studied the
biocompatibility of graphene and the contingent changes in the
expression of the protein GAP43, which is associated with the
growth of neurites. Their results showed high biocompatibility,
and highlighted a longer average length of neurites, as well as
better viability for cells grown on graphene, when compared
to polystyrene control substrates. The authors also found an
overexpression of the GAP43 protein, possibly the result of
improved neurites outgrowth due to both the high electrical
conductivity of graphene (as in CNTs) and by the wrinkled
nanoscale morphology of graphene layer. These properties
render graphene a good adhesion substrate to cells.
The use of graphene as an in vitro or an in vivo stimulator
device was the primary focus of a study conducted by Heo and
colleagues [95], who developed a graphene/PET film to test the
effects of a non-contact field stimulation on cell-to-cell coup-
ling. This film was found to be biocompatible and improved
cell proliferation and viability compared to those observed in
the control cultures; additionally, the electrical stimulation
resulted in affecting the regulation of cytoskeleton protein
related to cellular mobility, such as actin, resulting in morpholo-
gical changes in cellular edges.
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Figure 6: Three-dimensional graphene foam scaffolds allow neural stem cells to adhere and improve their proliferation by up-regulating Ki-67 protein
expression. Reproduced from [146] with permission. Copyright 2013 Nature Publishing Group.
Sahni et al. [139] compared the neurite outgrowth of rat prima-
ry cortical neurons cultured on bare, graphene- and poly-D-
lysine (PDL)-coated plastic polymer dishes, and found that neu-
ronal viability showed remarkable differences between
graphene and PDL substrates; the morphology of cells cultured
on graphene displayed more linear dendritic structures
compared to cells cultured on PDL and in control conditions.
The improved neuronal adhesion on graphene, compared to the
bare plastic polymeric dish, was ascribed by the authors to van
der Waals forces between cell membranes and graphene.
Similarly to NDs [140], surface charges can influence adhesion
and outgrowth of neuronal cells on graphene substrates. This
aspect has been investigated by Tu and colleagues [141], who
cultured primary rat hippocampal neurons on carboxylated GO
(GO-COOH; negative surface charge; control condition), the
surface of which had been chemically modified by functional-
isation with three functional groups: methoxy (-OCH3; almost
neutral surface charge), amino (NH2; positively charged
surface) and poly-m-aminobenzene sulfonic acid (-NH2/-SO3H,
PABS; zwitterionic). The viability of neurons after 7 DIV
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was estimated to be over 90% and, although no relevant differ-
ences in morphology were observed, neurons cultured on a
positively charged surface showed a greater number of neurites
per neuron, a longer length of neurites and a greater number
of branches per neurite. However, the lack of a direct compari-
son with the conventional control conditions (i.e., glass or
plastic, polymeric, culture substrates) makes it difficult to inter-
pret these results in terms of a possible application for neural
stimulation.
Graphene-based substrates have also been investigated as scaf-
folds for growth and for the differentiation of stem cells
[142,143]. The differentiation into neurons of human neural
stem cells (hNSCs), cultured on graphene has been studied by
Park et al. [144]; the results showed not only an improved dif-
ferentiation but also an enhanced cell adhesion and neurites for-
mation compared to control conditions. Moreover, the expres-
sion of laminin-related receptors and of genes involved in the
calcium signalling pathway was up-regulated for hNSCs grown
on graphene.
Akhavan et al. [145] studied the differentiation of hNSCs on
GO nanogrids deposited on a substrate made of TiO2 nano-
particles over SiO2, which made them photosensitive. The
authors observed an increase in cell growth and alignment along
the geometrical pattern of the nanogrids, further enhanced by
means of a repeated photo stimulation.
Li and co-workers [146] designed a three-dimensional graphene
foam scaffold for neural stem cells. This scaffold allowed the
formation of a three-dimensional neural network, resulting in an
excellent substrate for cell adhesion and proliferation by
up-regulating Ki-67 protein expression (Figure 6). To test
whether such a scaffold could be used as a neural stimulation
electrode, its electrochemical properties were investigated by
cyclic voltammetry, the results showing that electrical stimula-
tion via a capacitive charge injection was enhanced compared to
the use of conventional graphene film electrode; this was
due to the larger specific surface area of the three-dimensional
scaffold.
Conclusion
In this review, several reasons were established for why carbon-
based nanomaterials have gained more importance over the past
few years in the context of biomedical applications. We
reviewed their most important applications, with an emphasis
on the field of neuroscience and underlined their unique affinity
for neuronal interfacing.
Ultimately, additional research is required before a complete
understanding can be reached concerning how to best engineer
these nanomaterials for their use in advanced applications in the
fields of neuroscience and neuroprosthetics, as it relates to
biocompatibility, biodegradability, biostability and the exact
interaction mechanisms between these nanomaterials and neuro-
nal networks. The most recent results in this field, however, are
extremely promising and confirm the start of an important new
discipline at the interface between nanotechnologies and neuro-
science.
Acknowledgements
We are grateful to Drs. C. Bittencourt, M. Prato, L. Ballerini,
and M. Nesládek for discussions. We are also grateful to Drs.
Henry Markram, Sébastien Lasserre, and the Blue Brain Project
team at the EPFL for contributing the graphical abstract. Finan-
cial support from the European Commission (FP7-PEOPLE-
ITN "NAMASEN", contract n. 264872 and FP7-PEOPLE-IEF
“INCA-NANEP”, contract n. 328214; FP7-NMP "MERIDIAN"
project, contract n. 280778-02) and from the Belgian Science
Policy Office (BELSPO) is kindly acknowledged.
References
1. Iijima, S. Nature 1991, 354, 56–58. doi:10.1038/354056a0
2. Dresselhaus, M. S.; Dresselhaus, G.; Avouris, P. Carbon Nanotubes
Synthesis, Structure, Properties, and Applications; Springer: Berlin,
Germany, 2001.
3. Wilder, J. W. G.; Venema, L. C.; Rinzler, A. G.; Smalley, R. E.;
Dekker, C. Nature 1998, 391, 59–62. doi:10.1038/34139
4. Charlier, J.-C.; Blase, X.; Roche, S. Rev. Mod. Phys. 2007, 79,
677–732. doi:10.1103/RevModPhys.79.677
5. Shtogun, Y. V.; Woods, L. M. J. Phys. Chem. C 2009, 113,
4792–4796. doi:10.1021/jp807206m
6. Oliva-Avilés, A. I.; Avilés, F.; Sosa, V.; Oliva, A. I.; Gamboa, F.
Nanotechnology 2012, 23, 465710.
doi:10.1088/0957-4484/23/46/465710
7. Falvo, M. R.; Clary, G. J.; Taylor, R. M., II; Chi, V.; Brooks, F. P., Jr.;
Washburn, S.; Superfine, R. Nature 1997, 389, 582–584.
doi:10.1038/39282
8. Field, J. E. The Properties of natural and synthetic diamond;
Academic Press, 1992.
9. Liu, H. D.; Dandy, D. S. Diamond chemical vapor deposition:
Nucleation and Early Growth Stages; Noyes Publications: Park Ridge,
NJ, United States, 1995.
10. Kulakova, I. I. Phys. Solid State 2004, 46, 636–643.
doi:10.1134/1.1711440
11. Dement’ev, A. P.; Maslakov, K. I. Phys. Solid State 2004, 46,
678–680. doi:10.1134/1.1711450
12. Palosz, B.; Pantea, C.; Grzanka, E.; Stelmakh, S.; Proffen, Th.;
Zerda, T. W.; Palosz, W. Diamond Relat. Mater. 2006, 15,
1813–1817. doi:10.1016/j.diamond.2006.09.001
13. Krüger, A.; Kataoka, F.; Ozawa, M.; Fujino, T.; Suzuki, Y.;
Aleksenskii, A. E.; Vul’, A. Ya.; Ōsawa, E. Carbon 2005, 43,
1722–1730. doi:10.1016/j.carbon.2005.02.020
14. Krüger, A.; Liang, Y.; Jarre, G.; Stegk, J. J. Mater. Chem. 2006, 16,
2322. doi:10.1039/b601325b
Beilstein J. Nanotechnol. 2014, 5, 1849–1863.
1860
15. Aharonovich, I.; Castelletto, S.; Simpson, D. A.; Su, C.-H.;
Greentree, A. D.; Prawer, S. Rep. Prog. Phys. 2011, 74, 076501.
doi:10.1088/0034-4885/74/7/076501
16. Aleksenskii, A. E.; Osipov, V. Yu.; Vul’, A. Ya.; Ber, B. Ya.;
Smirnov, A. B.; Melekhin, V. G.; Adriaenssens, G. J.; Iakoubovskii, K.
Phys. Solid State 2001, 43, 145–150. doi:10.1134/1.1340200
17. Kompan, M. E.; Terukov, E. I.; Gordeev, S. K.; Zhukov, S. G.;
Nikolaev, Yu. A. Phys. Solid State 1997, 39, 1928–1929.
doi:10.1134/1.1130202
18. Doherty, M. W.; Manson, N. B.; Delaney, P.; Jelezko, F.;
Wrachtrup, J.; Hollenberg, L. C. L. Phys. Rep. 2013, 528, 1–45.
doi:10.1016/j.physrep.2013.02.001
19. Lee, S.-Y.; Widmann, M.; Rendler, T.; Doherty, M. W.; Babinec, T. M.;
Yang, S.; Eyer, M.; Siyushev, P.; Hausmann, B. J. M.; Loncar, M.;
Bodrog, Z.; Gali, A.; Manson, N. B.; Fedder, H.; Wrachtrup, J.
Nat. Nanotechnol. 2013, 8, 487–492. doi:10.1038/nnano.2013.104
20. Wrachtrup, J.; Jelezko, F. J. Phys.: Condens. Matter 2006, 18,
S807–S824. doi:10.1088/0953-8984/18/21/S08
21. Tisler, J.; Balasubramanian, G.; Naydenov, B.; Kolesov, R.; Grotz, B.;
Reuter, R.; Boudou, J.-P.; Curmi, P. A.; Sennour, M.; Thorel, A.;
Börsch, M.; Aulenbacher, K.; Erdmann, R.; Hemmer, P. R.;
Jelezko, F.; Wrachtrup, J. ACS Nano 2009, 3, 1959–1965.
doi:10.1021/nn9003617
22. Novoselov, K. S.; Geim, A. K.; Morozov, S. V.; Jiang, D.; Zhang, Y.;
Dubonos, S. V.; Grigorieva, I. V.; Firsov, A. A. Science 2004, 306,
666–669. doi:10.1126/science.1102896
23. Peierls, R. E. Ann. Inst. Henri Poincare 1935, 5, 177–222.
24. Mermin, N. D. Phys. Rev. 1968, 176, 250–254.
doi:10.1103/PhysRev.176.250
25. Novoselov, K. S.; Jiang, Z.; Zhang, Y.; Morozov, S. V.; Stormer, H. L.;
Zeitler, U.; Maan, J. C.; Boebinger, G. S.; Kim, P.; Geim, A. K.
Science 2007, 315, 1379. doi:10.1126/science.1137201
26. Bolotin, K. I.; Sikes, K. J.; Jiang, Z.; Klima, M.; Fudenberg, G.;
Hone, J.; Kim, P.; Stormer, H. L. Solid State Commun. 2008, 146,
351–355. doi:10.1016/j.ssc.2008.02.024
27. Novoselov, K. S.; Jiang, D.; Schedin, F.; Booth, T. J.;
Khotkevich, V. V.; Morozov, S. V.; Geim, A. K.
Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 10451–10453.
doi:10.1073/pnas.0502848102
28. Katsnelson, M. I.; Novoselov, K. S.; Geim, A. K. Nat. Phys. 2006, 2,
620–625. doi:10.1038/nphys384
29. Lee, C.; Wei, X.; Kysar, J. W.; Hone, J. Science 2008, 321, 385–388.
doi:10.1126/science.1157996
30. Nair, R. R.; Blake, P.; Grigorenko, A. N.; Novoselov, K. S.;
Booth, T. J.; Stauber, T.; Peres, N. M. R.; Geim, A. K. Science 2008,
320, 1308. doi:10.1126/science.1156965
31. Stoller, M. D.; Park, S.; Zhu, Y.; An, J.; Ruoff, R. S. Nano Lett. 2008,
8, 3498–3502. doi:10.1021/nl802558y
32. Yang, Z.; Zhang, Y.; Yang, Y.; Sun, L.; Han, D.; Li, H.; Wang, C.
Nanomedicine 2010, 6, 427–441. doi:10.1016/j.nano.2009.11.007
33. Flavin, K.; Kopf, I.; Del Canto, E.; Navio, C.; Bittencourt, C.;
Giordani, S. J. Mater. Chem. 2011, 21, 17881.
doi:10.1039/c1jm12217g
34. Georgakilas, V.; Kordatos, K.; Prato, M.; Guldi, D. M.; Holzinger, M.;
Hirsch, A. J. Am. Chem. Soc. 2002, 124, 760–761.
doi:10.1021/ja016954m
35. Richard, C.; Balavoine, F.; Schultz, P.; Ebbesen, T. W.;
Mioskowski, C. Science 2003, 300, 775–778.
doi:10.1126/science.1080848
36. Zheng, M.; Jagota, A.; Semke, E. D.; Diner, B. A.; McLean, R. S.;
Lustig, S. R.; Richardson, R. E.; Tassi, N. G. Nat. Mater. 2003, 2,
338–342. doi:10.1038/nmat877
37. Dyke, C. A.; Tour, J. M. Chem. – Eur. J. 2004, 10, 812–817.
doi:10.1002/chem.200305534
38. Dyke, C. A.; Tour, J. M. J. Phys. Chem. A 2004, 108, 11151–11159.
doi:10.1021/jp046274g
39. Tagmatarchis, N.; Prato, M. J. Mater. Chem. 2004, 14, 437.
doi:10.1039/b314039c
40. Khabashesku, V. N. Russ. Chem. Rev. 2011, 80, 705–725.
doi:10.1070/RC2011v080n08ABEH004232
41. Coleman, K. S.; Bailey, S. R.; Fogden, S.; Green, M. L. H.
J. Am. Chem. Soc. 2003, 125, 8722–8723. doi:10.1021/ja0355675
42. Liang, F.; Sadana, A. K.; Peera, A.; Chattopadhyay, J.; Gu, Z.;
Hauge, R. H.; Billups, W. E. Nano Lett. 2004, 4, 1257–1260.
doi:10.1021/nl049428c
43. Yang, M.; Flavin, K.; Kopf, I.; Radics, G.; Hearnden, C. H.;
McManus, G. J.; Moran, B.; Villalta-Cerdas, A.; Echegoyen, L. A.;
Giordani, S.; Lavelle, E. C. Small 2013, 9, 4194–4206.
doi:10.1002/smll.201300481
44. Porter, A. E.; Gass, M.; Muller, K.; Skepper, J. N.; Midgley, P. A.;
Welland, M. Nat. Nanotechnol. 2007, 2, 713–717.
doi:10.1038/nnano.2007.347
45. Shvedova, A. A.; Kisin, E. R.; Mercer, R.; Murray, A. R.;
Johnson, V. J.; Potapovich, A. I.; Tyurina, Y. Y.; Gorelik, O.;
Arepalli, S.; Schwegler-Berry, D.; Hubbs, A. F.; Antonini, J.;
Evans, D. E.; Ku, B. K.; Ramsey, D.; Maynard, A.; Kagan, V. E.;
Castanova, V.; Baron, P. Am. J. Physiol.: Lung Cell. Mol. Physiol.
2005, 289, L698–L708. doi:10.1152/ajplung.00084.2005
46. Poland, C. A.; Duffin, R.; Kinloch, I.; Maynard, A.; Wallace, W. A. H.;
Seaton, A.; Stone, V.; Brown, S.; Macnee, W.; Donaldson, K.
Nat. Nanotechnol. 2008, 3, 423–428. doi:10.1038/nnano.2008.111
47. Bottini, M.; Bruckner, S.; Nika, K.; Bottini, N.; Bellucci, S.; Magrini, A.;
Bergamaschi, A.; Mustelin, T. Toxicol. Lett. 2006, 160, 121–126.
doi:10.1016/j.toxlet.2005.06.020
48. Ding, L.; Stilwell, J.; Zhang, T.; Elboudwarej, O.; Jiang, H.;
Selegue, J. P.; Cooke, P. A.; Gray, J. W.; Chen, F. F. Nano Lett.
2005, 5, 2448–2464. doi:10.1021/nl051748o
49. Dumortier, H.; Lacotte, S.; Pastorin, G.; Marega, R.; Wu, W.;
Bonifazi, D.; Briand, J. P.; Prato, M.; Muller, S.; Bianco, A. Nano Lett.
2006, 6, 1522–1528. doi:10.1021/nl061160x
50. Yehia, H. N.; Draper, R. K.; Mikoryak, C.; Walker, E. K.; Bajaj, P.;
Musselman, I. H.; Daigrepont, M. C.; Dieckmann, G. R.; Pantano, P.
J. Nanobiotechnol. 2007, 5, No. 8. doi:10.1186/1477-3155-5-8
51. Wu, W.; Li, R.; Bian, X.; Zhu, Z.; Ding, D.; Li, X.; Jia, Z.; Jiang, X.;
Hu, Y. ACS Nano 2009, 3, 2740–2750. doi:10.1021/nn9005686
52. Pantarotto, D.; Singh, R.; McCarthy, D.; Erhardt, M.; Briand, J.-P.;
Prato, M.; Kostarelos, K.; Bianco, A. Angew. Chem. 2004, 116,
5354–5358. doi:10.1002/ange.200460437
53. Gao, L.; Nie, L.; Wang, T.; Qin, Y.; Guo, Z.; Yang, D.; Yan, X.
ChemBioChem 2006, 7, 239–242. doi:10.1002/cbic.200500227
54. Cella, L. N.; Chen, W.; Myung, N. V.; Mulchandani, A.
J. Am. Chem. Soc. 2010, 132, 5024–5026. doi:10.1021/ja100503b
55. Madani, S. Y.; Naderi, N.; Dissanayake, O.; Tan, A.; Seifalian, A. M.
Int. J. Nanomed. 2011, 6, 2963–2979. doi:10.2147/IJN.S16923
56. Elhissi, A. M. A.; Ahmed, W.; Ul Hassan, I.; Dhanak, V. R.;
D'Emanuele, A. J. Drug Delivery 2012, 837327.
doi:10.1155/2012/837327
57. Hirata, E.; Uo, M.; Takita, H.; Akasaka, T.; Watari, F.; Yokoyama, A.
Carbon 2011, 49, 3284–3291. doi:10.1016/j.carbon.2011.04.002
Beilstein J. Nanotechnol. 2014, 5, 1849–1863.
1861
58. Zavaleta, C.; de la Zerda, A.; Liu, Z.; Keren, S.; Cheng, Z.;
Schipper, M.; Chen, X.; Dai, H.; Gambhir, S. S. Nano Lett. 2008, 8,
2800–2805. doi:10.1021/nl801362a
59. Jin, H.; Heller, D. A.; Strano, M. S. Nano Lett. 2008, 8, 1577–1585.
doi:10.1021/nl072969s
60. Sucapane, A.; Cellot, G.; Prato, M.; Giugliano, M.; Parpura, V.;
Ballerini, L. J. Nanoneurosci. 2009, 1, 10–16.
doi:10.1166/jns.2009.002
61. Chan, V.; Raman, R.; Cvetkovic, C.; Bashir, R. ACS Nano 2013, 7,
1830–1837. doi:10.1021/nn401098c
62. Martinelli, V.; Cellot, G.; Toma, F. M.; Long, C. S.; Caldwell, J. H.;
Zentilin, L.; Giacca, M.; Turco, A.; Prato, M.; Ballerini, L.; Mestroni, L.
Nano Lett. 2012, 12, 1831–1838. doi:10.1021/nl204064s
63. Martinelli, V.; Cellot, G.; Toma, F. M.; Long, C. S.; Caldwell, J. H.;
Zentilin, L.; Giacca, M.; Turco, A.; Prato, M.; Ballerini, L.; Mestroni, L.
ACS Nano 2013, 7, 5746–5756. doi:10.1021/nn4002193
64. Lin, Z. Q.; Liu, L. H.; Xi, Z. G.; Huang, J. H.; Lin, B. C.
Int. J. Nanomed. 2012, 7, 4199–4206. doi:10.2147/IJN.S34663
65. Huang, H.; Pierstorff, E.; Ōsawa, E.; Ho, D. Nano Lett. 2007, 7,
3305–3314. doi:10.1021/nl071521o
66. Li, J.; Zhu, Y.; Li, W.; Zhang, X.; Peng, Y.; Huang, Q. Biomaterials
2010, 31, 8410–8418. doi:10.1016/j.biomaterials.2010.07.058
67. Metzler, P.; von Wilmowsky, C.; Stadlinger, B.; Zemann, W.;
Schlegel, K. A.; Rosiwal, S.; Rupprecht, S.
J. Cranio-Maxillofacial Surg. 2013, 41, 532–538.
doi:10.1016/j.jcms.2012.11.020
68. Chang, I. P.; Hwang, K. C.; Chiang, C.-S. J. Am. Chem. Soc. 2008,
130, 15476–15481. doi:10.1021/ja804253y
69. Yu, S.-J.; Kang, M.-W.; Chang, H.-C.; Chen, K.-M.; Yu, Y.-C.
J. Am. Chem. Soc. 2005, 127, 17604–17605. doi:10.1021/ja0567081
70. Schrand, A. M.; Dai, L.; Schlager, J. J.; Hussain, S. M.; Ōsawa, E.
Diamond Relat. Mater. 2007, 16, 2118–2123.
doi:10.1016/j.diamond.2007.07.020
71. Schrand, A. M.; Huang, H.; Carlson, C.; Schlager, J. J.;
Omacr Sawa, E.; Hussain, S. M.; Dai, L. J. Phys. Chem. B 2007, 111,
2–7. doi:10.1021/jp066387v
72. Schrand, A. M.; Lin, J. B. Characterization of Detonation
Nanodiamonds. In Ultrananocrystalline Diamond, 2nd ed.;
Shenderova, O. A.; Gruen, D. M., Eds.; Elsevier, 2012; pp 519–548.
doi:10.1016/B978-1-4377-3465-2.00016-5
73. Bakowicz-Mitura, K.; Bartosz, G.; Mitura, S. Surf. Coat. Technol.
2007, 201, 6131–6135. doi:10.1016/j.surfcoat.2006.08.142
74. Xing, Y.; Xiong, W.; Zhu, L.; Ōsawa, E.; Hussin, S.; Dai, L. ACS Nano
2011, 5, 2376–2384. doi:10.1021/nn200279k
75. Vaijayanthimala, V.; Tzeng, Y.-K.; Chang, H.-C.; Li, C.-L.
Nanotechnology 2009, 20, 425103.
doi:10.1088/0957-4484/20/42/425103
76. Schrand, A. M.; Lin, J. B.; Hens, S. C.; Hussain, S. M. Nanoscale
2011, 3, 435–445. doi:10.1039/c0nr00408a
77. Yuan, Y.; Wang, X.; Jia, G.; Liu, J.-H.; Wang, T.; Gu, Y.; Yang, S.-T.;
Zhen, S.; Wang, H.; Liu, Y. Diamond Relat. Mater. 2010, 19, 291–299.
doi:10.1016/j.diamond.2009.11.022
78. Puzyr, A. P.; Baron, A. V.; Purtov, K. V.; Bortnikov, E. V.;
Skobelev, N. N.; Mogilnaya, O. A.; Bondar, V. S.
Diamond Relat. Mater. 2007, 16, 2124–2128.
doi:10.1016/j.diamond.2007.07.025
79. Yuan, Y.; Chen, Y.; Liu, J.-H.; Wang, H.; Liu, Y.
Diamond Relat. Mater. 2009, 18, 95–100.
doi:10.1016/j.diamond.2008.10.031
80. Rojas, S.; Gispert, J. D.; Martín, R.; Abad, S.; Menchón, C.;
Pareto, D.; Victor, V. M.; Álvaro, M.; García, H.; Herance, J. R.
ACS Nano 2011, 5, 5552–5559. doi:10.1021/nn200986z
81. Lam, R.; Chen, M.; Pierstorff, E.; Huang, H.; Ōsawa, E.; Ho, D.
ACS Nano 2008, 2, 2095–2102. doi:10.1021/nn800465x
82. Chen, M.; Pierstorff, E. D.; Lam, R.; Li, S. Y.; Huang, H.; Ōsawa, E.;
Ho, D. ACS Nano 2009, 3, 2016–2022. doi:10.1021/nn900480m
83. Adnan, A.; Lam, R.; Chen, H.; Lee, J.; Schaffer, D. J.; Barnard, A. S.;
Schatz, G. C.; Ho, D.; Liu, W. K. Mol. Pharmaceutics 2011, 8,
368–374. doi:10.1021/mp1002398
84. Li, Y.; Zhou, X.; Wang, D.; Yang, B.; Yang, P. J. Mater. Chem. 2011,
21, 16406. doi:10.1039/c1jm10926j
85. Bondar’, V. S.; Pozdnyakova, I. O.; Puzyr’, A. P. Phys. Solid State
2004, 46, 758–760. doi:10.1134/1.1711468
86. Kong, X. L.; Huang, L. C. L.; Hsu, C.-M.; Chen, W.-H.; Han, C.-C.;
Chang, H.-C. Anal. Chem. 2005, 77, 259–265.
doi:10.1021/ac048971a
87. Akhavan, O.; Ghaderi, E.; Akhavan, A. Biomaterials 2012, 33,
8017–8025. doi:10.1016/j.biomaterials.2012.07.040
88. Chang, Y.; Yang, S.-T.; Liu, J.-H.; Dong, E.; Wang, Y.; Cao, A.;
Liu, Y.; Wang, H. Toxicol. Lett. 2011, 200, 201–210.
doi:10.1016/j.toxlet.2010.11.016
89. Yuan, J.; Gao, H.; Sui, J.; Duan, H.; Chen, W. N.; Ching, C. B.
Toxicol. Sci. 2012, 126, 149–161. doi:10.1093/toxsci/kfr332
90. Yue, H.; Wei, W.; Yue, Z.; Wang, B.; Luo, N.; Gao, Y.; Ma, D.; Ma, G.;
Su, Z. Biomaterials 2012, 33, 4013–4021.
doi:10.1016/j.biomaterials.2012.02.021
91. Feng, L.; Zhang, S.; Liu, Z. Nanoscale 2011, 3, 1252–1257.
doi:10.1039/c0nr00680g
92. Sun, X.; Liu, Z.; Welsher, K.; Robinson, J. T.; Goodwin, A.; Zaric, S.;
Dai, H. Nano Res. 2008, 1, 203–212. doi:10.1007/s12274-008-8021-8
93. Hong, H.; Yang, K.; Zhang, Y.; Engle, J. W.; Feng, L.; Yang, Y.;
Nayak, T. R.; Goel, S.; Bean, J.; Theuer, C. P.; Barnhart, T. E.; Liu, Z.;
Cai, W. ACS Nano 2012, 6, 2361–2370. doi:10.1021/nn204625e
94. Kalbacova, M.; Broz, A.; Kong, J.; Kalbac, M. Carbon 2010, 48,
4323–4329. doi:10.1016/j.carbon.2010.07.045
95. Heo, C.; Yoo, J.; Lee, S.; Jo, A.; Jung, S.; Yoo, H.; Lee, Y. H.; Suh, M.
Biomaterials 2011, 32, 19–27. doi:10.1016/j.biomaterials.2010.08.095
96. Yang, K.; Zhang, S.; Zhang, G.; Sun, X.; Lee, S.-T.; Liu, Z. Nano Lett.
2010, 10, 3318–3323. doi:10.1021/nl100996u
97. Yang, K.; Wan, J.; Zhang, S.; Tian, B.; Zhang, Y.; Liu, Z. Biomaterials
2012, 33, 2206–2214. doi:10.1016/j.biomaterials.2011.11.064
98. Dey, R. S.; Raj, C. R. J. Phys. Chem. C 2010, 114, 21427–21433.
doi:10.1021/jp105895a
99. Tang, L.; Wang, Y.; Li, Y.; Feng, H.; Lu, J.; Li, J. Adv. Funct. Mater.
2009, 19, 2782–2789. doi:10.1002/adfm.200900377
100.Kim, Y. R.; Bong, S.; Kang, Y. J.; Yang, Y.; Mahajan, R. K.; Kim, J. S.;
Kim, H. Biosens. Bioelectron. 2010, 25, 2366–2369.
doi:10.1016/j.bios.2010.02.031
101.Sun, C.-L.; Lee, H.-H.; Yang, J.-M.; Wu, C.-C. Biosens. Bioelectron.
2011, 26, 3450–3455. doi:10.1016/j.bios.2011.01.023
102.Yang, X.; Zhang, X.; Liu, Z.; Ma, Y.; Huang, Y.; Chen, Y.
J. Phys. Chem. C 2008, 112, 17554–17558. doi:10.1021/jp806751k
103.Zhang, L.; Xia, J.; Zhao, Q.; Liu, L.; Zhang, Z. Small 2010, 6,
537–544. doi:10.1002/smll.200901680
104.Weaver, C. L.; Larosa, J. M.; Luo, X.; Cui, X. T. ACS Nano 2014, 8,
1834–1843. doi:10.1021/nn406223e
105.Mattson, M. P.; Haddon, R. C.; Rao, A. M. J. Mol. Neurosci. 2000, 14,
175–182. doi:10.1385/JMN:14:3:175
Beilstein J. Nanotechnol. 2014, 5, 1849–1863.
1862
106.Voge, C. M.; Stegemann, J. P. J. Neural Eng. 2011, 8, 011001.
doi:10.1088/1741-2560/8/1/011001
107.Malarkey, E. B.; Parpura, V. Neurodegener. Dis. 2007, 4, 292–299.
doi:10.1159/000101885
108.Ben-Jacob, E.; Hanein, Y. J. Mater. Chem. 2008, 18, 5181.
doi:10.1039/b805878b
109.Keefer, E. W.; Botterman, B. R.; Romero, M. I.; Rossi, A. F.;
Gross, G. W. Nat. Nanotechnol. 2008, 3, 434–439.
doi:10.1038/nnano.2008.174
110.Malarkey, E. B.; Fisher, K. A.; Bekyarova, E.; Liu, W.; Haddon, R. C.;
Parpura, V. Nano Lett. 2009, 9, 264–268. doi:10.1021/nl802855c
111.Gabay, T.; Ben-David, M.; Kalifa, I.; Sorkin, R.; Abrams, Z. R.;
Ben-Jacob, E.; Hanein, Y. Nanotechnology 2007, 18, 035201.
doi:10.1088/0957-4484/18/3/035201
112.Gabriel, G.; Gómez, R.; Bongard, M.; Benito, N.; Fernández, E.;
Villa, R. Biosens. Bioelectron. 2009, 24, 1942–1948.
doi:10.1016/j.bios.2008.09.036
113.Shein, M.; Greenbaum, A.; Gabay, T.; Sorkin, R.; David-Pur, M.;
Ben-Jacob, E.; Hanein, Y. Biomed. Microdevices 2009, 11, 495–501.
doi:10.1007/s10544-008-9255-7
114.Fuchsberger, K.; Le Goff, A.; Gambazzi, L.; Toma, F. M.; Goldoni, A.;
Giugliano, M.; Stelzle, M.; Prato, M. Small 2011, 7, 524–530.
doi:10.1002/smll.201001640
115.Gerwig, R.; Fuchsberger, K.; Schroeppel, B.; Link, G. S.; Heusel, G.;
Kraushaar, U.; Schuhmann, W.; Stett, A.; Stelzle, M. Front. Neuroeng.
2012, 5, No. 8. doi:10.3389/fneng.2012.00008
116.Lin, C.-M.; Lee, Y.-T.; Yeh, S.-R.; Fang, W. Biosens. Bioelectron.
2009, 24, 2791–2797. doi:10.1016/j.bios.2009.02.005
117.David-Pur, M.; Bareket-Keren, L.; Beit-Yaakov, G.; Raz-Prag, D.;
Hanein, Y. Biomed. Microdevices 2014, 16, 43–53.
doi:10.1007/s10544-013-9804-6
118.Lovat, V.; Pantarotto, D.; Lagostena, L.; Cacciari, B.; Grandolfo, M.;
Righi, M.; Spalluto, G.; Prato, M.; Ballerini, L. Nano Lett. 2005, 5,
1107–1110. doi:10.1021/nl050637m
119.Mazzatenta, A.; Giugliano, M.; Campidelli, S.; Gambazzi, L.;
Businaro, L.; Markram, H.; Prato, M.; Ballerini, L. J. Neurosci. 2007,
27, 6931–6936. doi:10.1523/JNEUROSCI.1051-07.2007
120.Sorkin, R.; Greenbaum, A.; David-Pur, M.; Anava, S.; Ayali, A.;
Ben-Jacob, E.; Hanein, Y. Nanotechnology 2009, 20, 015101.
doi:10.1088/0957-4484/20/1/015101
121.Cellot, G.; Cilia, E.; Cipollone, S.; Rancic, V.; Sucapane, A.;
Giordani, S.; Gambazzi, L.; Markram, H.; Grandolfo, M.; Scaini, D.;
Gelain, F.; Casalis, L.; Prato, M.; Giugliano, M.; Ballerini, L.
Nat. Nanotechnol. 2009, 4, 126–133. doi:10.1038/nnano.2008.374
122.Fabbro, A.; Sucapane, A.; Toma, F. M.; Calura, E.; Rizzetto, L.;
Carrieri, C.; Roncaglia, P.; Martinelli, V.; Scaini, D.; Masten, L.;
Turco, A.; Gustincich, S.; Prato, M.; Ballerini, L. PLoS One 2013, 8,
No. e73621. doi:10.1371/journal.pone.0073621
123.Cellot, G.; Toma, F. M.; Varley, Z. K.; Laishram, J.; Villari, A.;
Quintana, M.; Cipollone, S.; Prato, M.; Ballerini, L. J. Neurosci. 2011,
31, 12945–12953. doi:10.1523/JNEUROSCI.1332-11.2011
124.Fabbro, A.; Villari, A.; Laishram, J.; Scaini, D.; Toma, F. M.; Turco, A.;
Prato, M.; Ballerini, L. ACS Nano 2012, 6, 2041–2055.
doi:10.1021/nn203519r
125.Specht, C. G.; Williams, O. A.; Jackman, R. B.; Schoepfer, R.
Biomaterials 2004, 25, 4073–4078.
doi:10.1016/j.biomaterials.2003.11.006
126.Ariano, P.; Baldelli, P.; Carbone, E.; Gilardino, A.; Lo Giudice, A.;
Lovisolo, D.; Manfredotti, C.; Novara, M.; Sternschulte, H.; Vittone, E.
Diamond Relat. Mater. 2005, 14, 669–674.
doi:10.1016/j.diamond.2004.11.021
127.May, P. W.; Regan, E. M.; Taylor, A.; Uney, J.; Dick, A. D.;
McGeehan, J. Diamond Relat. Mater. 2012, 23, 100–104.
doi:10.1016/j.diamond.2012.01.023
128.Ariano, P.; Lo Giudice, A.; Marcantoni, A.; Vittone, E.; Carbone, E.;
Lovisolo, D. Biosens. Bioelectron. 2009, 24, 2046–2050.
doi:10.1016/j.bios.2008.10.017
129.Ho-Yin, C.; Aslam, D. M.; Wiler, J. A.; Casey, B.
J. Microelectromech. Syst. 2009, 18, 511–521.
doi:10.1109/JMEMS.2009.2015493
130.Thalhammer, A.; Edgington, R. J.; Cingolani, L. A.; Schoepfer, R.;
Jackman, R. B. Biomaterials 2010, 31, 2097–2104.
doi:10.1016/j.biomaterials.2009.11.109
131.Garrett, D. J.; Ganesan, K.; Stacey, A.; Fox, K.; Meffin, H.; Prawer, S.
J. Neural Eng. 2012, 9, 016002. doi:10.1088/1741-2560/9/1/016002
132.Halpern, J. M.; Cullins, M. J.; Chiel, H. J.; Martin, H. B.
Diamond Relat. Mater. 2010, 19, 178–181.
doi:10.1016/j.diamond.2009.08.006
133.Bonnauron, M.; Saada, S.; Mer, C.; Gesset, C.; Williams, O. A.;
Rousseau, L.; Scorsone, E.; Mailley, P.; Nesladek, M.; Arnault, J.-C.;
Bergonzo, P. Phys. Status Solidi A 2008, 205, 2126–2129.
doi:10.1002/pssa.200879733
134.Feoktistov, N. A.; Grudinkin, S. A.; Rybin, M. V.; Smirnov, A. N.;
Aleksenskii, A. E.; Vul’, A. Y.; Golubev, V. G. Tech. Phys. Lett. 2011,
37, 322–325. doi:10.1134/S1063785011040079
135.Bennet, K.; Lee, K.; Kruchowski, J.; Chang, S.-Y.; Marsh, M.;
Van Orsow, A.; Paez, A.; Manciu, F. Materials 2013, 6, 5726–5741.
doi:10.3390/ma6125726
136.Kaufmann, S.; Simpson, D. A.; Hall, L. T.; Perunicic, V.; Senn, P.;
Steinert, S.; McGuinness, L. P.; Johnson, B. C.; Ohshima, T.;
Caruso, F.; Wrachtrup, J.; Scholten, R. E.; Mulvaney, P.;
Hollenberg, L. Proc. Natl. Acad. Sci. U. S. A. 2013, 110,
10894–10898. doi:10.1073/pnas.1300640110
137.Hall, L. T.; Beart, G. C. C.; Thomas, E. A.; Simpson, D. A.;
McGuinness, L. P.; Cole, J. H.; Manton, J. H.; Scholten, R. E.;
Jelezko, F.; Wrachtrup, J.; Petrou, S.; Hollenberg, L. C. L. Sci. Rep.
2012, 2, No. 401. doi:10.1038/srep00401
138.Li, N.; Zhang, X.; Song, Q.; Su, R.; Zhang, Q.; Kong, T.; Liu, L.;
Jin, G.; Tang, M.; Cheng, G. Biomaterials 2011, 32, 9374–9382.
doi:10.1016/j.biomaterials.2011.08.065
139.Sahni, D.; Jea, A.; Mata, J. A.; Marcano, D. C.; Sivaganesan, A.;
Berlin, J. M.; Tatsui, C. E.; Sun, Z.; Luerssen, T. G.; Meng, S.;
Kent, T. A.; Tour, J. M. J. Neurosurg.: Pediatr. 2013, 11, 575–583.
doi:10.3171/2013.1.PEDS12374
140.Lechleitner, T.; Klauser, F.; Seppi, T.; Lechner, J.; Jennings, P.;
Perco, P.; Mayer, B.; Steinmuller-Nethl, D.; Preiner, J.;
Hinterdorfer, P.; Hermann, M.; Bertel, E.; Pfaller, K.; Pfaller, W.
Biomaterials 2008, 29, 4275–4284.
doi:10.1016/j.biomaterials.2008.07.023
141.Tu, Q.; Pang, L.; Chen, Y.; Zhang, Y.; Zhang, R.; Lu, B.; Wang, J.
Analyst 2014, 139, 105–115. doi:10.1039/c3an01796f
142.Nayak, T. R.; Andersen, H.; Makam, V. S.; Khaw, C.; Bae, S.; Xu, X.;
Ee, P.-L. R.; Ahn, J.-H.; Hong, B. H.; Pastorin, G.; Ozyilmaz, B.
ACS Nano 2011, 5, 4670–4678. doi:10.1021/nn200500h
143.Lee, W. C.; Lim, C. H. Y. X.; Shi, H.; Tang, L. A. L.; Wang, Y.;
Lim, C. T.; Loh, K. P. ACS Nano 2011, 5, 7334–7341.
doi:10.1021/nn202190c
Beilstein J. Nanotechnol. 2014, 5, 1849–1863.
1863
144.Park, S. Y.; Park, J.; Sim, S. H.; Sung, M. G.; Kim, K. S.; Hong, B. H.;
Hong, S. Adv. Mater. 2011, 23, H263–H267.
doi:10.1002/adma.201101503
145.Akhavan, O.; Ghaderi, E. J. Mater. Chem. B 2013, 1, 6291.
doi:10.1039/c3tb21085e
146.Li, N.; Zhang, Q.; Gao, S.; Song, Q.; Huang, R.; Wang, L.; Liu, L.;
Dai, J.; Tang, M.; Cheng, G. Sci. Rep. 2013, 3, No. 1604.
doi:10.1038/srep01604
License and Terms
This is an Open Access article under the terms of the
Creative Commons Attribution License
(http://creativecommons.org/licenses/by/2.0), which
permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
The license is subject to the Beilstein Journal of
Nanotechnology terms and conditions:
(http://www.beilstein-journals.org/bjnano)
The definitive version of this article is the electronic one
which can be found at:
doi:10.3762/bjnano.5.196
